Shehnaaz Suliman's Net Worth
$4.97 Million
Who is Shehnaaz Suliman?
Shehnaaz Suliman has an estimated net worth of $4.97 Million. This is based on reported shares across multiple companies, which include Theravance Biopharma, Inc., 10x Genomics, Inc., Alector, Inc., and Ultragenyx Pharmaceutical Inc..
SEC CIK
Shehnaaz Suliman's CIK is 0001713070
Past Insider Trading and Trends
2021 was Shehnaaz Suliman's most active year for acquiring shares with 10 total transactions. Shehnaaz Suliman's most active month to acquire stocks was the month of May. 2021 was Shehnaaz Suliman's most active year for disposing of shares, totalling 13 transactions. Shehnaaz Suliman's most active month to dispose stocks was the month of November. 2021 saw Shehnaaz Suliman paying a total of $4,783,242.87 for 408,458 shares, this is the most they've acquired in one year. In 2021 Shehnaaz Suliman cashed out on 600,000 shares for a total of $6,646,474.76, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Theravance Biopharma, Inc. (TBPH) Snapshot price: $8.01
SVP, Corp Dev & Strategy
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -5.60% | -5.76K |
$27.00 | -$155,601.00 | 97.2K |
Feb 20
| |||
Form 4
| -7.97% | -8.77K |
$29.09 | -$255,119.30 | 101.23K |
Feb 20
| |||
Form 4
| +450.00% | 90K |
—
|
—
| 110K |
Feb 12
| |||
Form 4
|
∞
| 20K |
—
|
—
| 20K |
Aug 1
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
10x Genomics, Inc. (TXG) Snapshot price: $22.65
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +187.61% | 8.65K |
—
|
—
| 13.26K |
Jun 11
| |||
Form 4
| +67.94% | 1.86K |
—
|
—
| 4.61K |
Jun 14
| |||
Form 4
| +339.20% | 2.12K |
—
|
—
| 2.75K |
Jun 15
| |||
Form 4
|
∞
| 625 |
—
|
—
| 625 |
Jun 11
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 16
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Alector, Inc. (ALEC) Snapshot price: $4.85
President and COO
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
$19.37 | -$640,815.88 | 102.6K |
Scheduled
|
Dec 10 - Dec 13
| ||
Form 4
|
—
|
0
|
$18.74 | -$1,222,416.02 | 102.6K |
Scheduled
|
Dec 8 - Dec 9
| ||
Form 4
|
∞
| 100K |
—
|
—
| 100K |
May 7
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Oct 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 1
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Ultragenyx Pharmaceutical Inc. (RARE) Snapshot price: $55.24
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +35.98% | 5.34K |
—
|
—
| 20.2K |
Jun 18
| |||
Form 4
| +35.11% | 3.86K |
—
|
—
| 14.86K |
Jun 7
| |||
Form 4
| +42.88% | 3.3K |
—
|
—
| 10.99K |
Jun 24
| |||
Form 4
| +38.65% | 2.15K |
—
|
—
| 7.7K |
Jun 24
| |||
Form 4
| +85.00% | 2.55K |
—
|
—
| 5.55K |
Jun 26
| |||
Form 4
|
∞
| 3K |
—
|
—
| 3K |
Jun 11
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 30
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||